Case Study: Guillain-Barré Syndrome (GBS)

Authors

  • S. Arun Sathya Dev Professor, Department of Pharmaceutical Chemistry, Avanthi Institute of Pharmaceutical Sciences
  • M.Roja Avanthi Institute of Pharmaceutical Sciences, Tagarapuvalasa, Andhra Pradesh, India.
  • L.Satish Kumar Achari Avanthi Institute of Pharmaceutical Sciences, Tagarapuvalasa, Andhra Pradesh, India.

Keywords:

Guillain-Barré Syndrome, paralysis, respiratory failure

Abstract

Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder characterized by progressive muscle weakness, paralysis, and in severe cases, respiratory failure. This case study provides an in-depth analysis of a patient diagnosed with Guillain-Barré Syndrome, focusing on clinical presentation, diagnostic challenges, treatment modalities, and the patient's management journey.

Downloads

Download data is not yet available.

References

Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012 Jun 14;366(24):2294-304.

Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014 Jan;137(Pt 1):33-43.

Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016 Aug 13;388(10045):717-27. [PubMed]

Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005;366:1653–66.

Ortiz-Salas P, Velez-Van-Meerbeke A, Galvis-Gomez CA, Rodriguez Q JH. Human Immunoglobulin Versus Plasmapheresis in Guillain-Barre Syndrome and Myasthenia Gravis: A Meta-Analysis. J Clin Neuromuscul Dis. 2016 Sep;18(1):1-11.

Published

31-03-2022

How to Cite

S, A. S. D., M, R., & L, S. K. A. (2022). Case Study: Guillain-Barré Syndrome (GBS). International Journal of Current Innovations in Advanced Research, 5(1), 12–14. Retrieved from https://ijciar.com/index.php/journal/article/view/166

Issue

Volume 5, Issue 1, 2022

Section

Case Studies & Reports
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.